Antisense oligonucleotides for atherosclerotic disease
- PMID: 32251402
- DOI: 10.1038/s41591-020-0835-2
Antisense oligonucleotides for atherosclerotic disease
Comment on
-
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.N Engl J Med. 2020 Jan 16;382(3):244-255. doi: 10.1056/NEJMoa1905239. Epub 2020 Jan 1. N Engl J Med. 2020. PMID: 31893580 Clinical Trial.
References
-
- Tsimikas, S. et al. J. Am. Coll. Cardiol. 71, 177–192 (2018). - DOI
-
- Tsimikas, S. et al. N. Engl. J. Med. 382, 244–255 (2020). - DOI
-
- Paré, G. et al. Circulation 139, 1472–1482 (2019). - DOI
-
- Clarke, R. et al. N. Engl. J. Med. 361, 2518–2528 (2009). - DOI
-
- Burgess, S. et al. JAMA Cardiol. 3, 619–627 (2018). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical